{"gene":"DERA","run_date":"2026-04-28T17:46:02","timeline":{"discoveries":[{"year":1982,"finding":"DERA (deoC gene product) is a class I aldolase of 259 amino acids (MW ~27,737) that forms Schiff base intermediates during catalysis. The enzyme can exist as both a monomer and dimer, and a lysine residue in the active site was tentatively identified as the catalytic nucleophile involved in Schiff base formation.","method":"Protein purification, amino acid sequencing, nucleotide sequencing, catalytic activity assays","journal":"European journal of biochemistry","confidence":"High","confidence_rationale":"Tier 1 — direct biochemical characterization with sequence determination and active-site identification","pmids":["6749498"],"is_preprint":false},{"year":1997,"finding":"Deoxyriboaldolase (DERA) activity is present in liver of several vertebrates and in multiple cell lines, enabling channelling of deoxyribose-5-phosphate (derived from exogenous DNA or deoxynucleosides) into glycolysis. In Bacillus cereus, switching to anaerobic conditions further increased DERA activity, enhancing deoxyribose utilization as a carbon/energy source.","method":"Enzyme activity assays in cell lines and vertebrate liver extracts; bacterial induction experiments under aerobic/anaerobic conditions","journal":"Comparative biochemistry and physiology. Part B, Biochemistry & molecular biology","confidence":"Medium","confidence_rationale":"Tier 2 — multiple cell lines/tissues tested, but no mutagenesis or structural validation","pmids":["9226884"],"is_preprint":false},{"year":2014,"finding":"Human DERA is the deoxyribose phosphate aldolase that converts 2-deoxy-D-ribose-5-phosphate into glyceraldehyde-3-phosphate and acetaldehyde. DERA interacts with the stress granule component YBX1 and is recruited to stress granules upon oxidative or mitochondrial stress. shRNA-mediated knockdown of DERA reduced stress granule formation and increased apoptosis after clotrimazole stress. Additionally, DERA expression enables cells with abolished mitochondrial ATP production to use extracellular deoxyinosine to maintain ATP levels via deoxynucleoside degradation.","method":"shRNA knockdown, deoxyribose phosphate aldolase activity assays, co-immunoprecipitation with YBX1, immunofluorescence of stress granules, ATP level measurements","journal":"Biochimica et biophysica acta","confidence":"High","confidence_rationale":"Tier 2 — multiple orthogonal methods: enzymatic assay, Co-IP, KD with defined phenotypic readouts","pmids":["25229427"],"is_preprint":false},{"year":2015,"finding":"The non-canonical phosphate-binding site of DERA (residues Ser238 and Ser239) contributes to catalytic efficiency through coupled protein dynamics. The S239P mutant showed increased enthalpy but decreased entropy at the transition state, with a concomitant loss of anti-correlated motions across the protein. These anti-correlated motions are coupled to catalytic efficiency in the retro-aldol cleavage reaction.","method":"Site-directed mutagenesis, site-saturation mutagenesis, kinetic analysis, molecular dynamics simulations, temperature-dependence of catalytic rates","journal":"Chemical science","confidence":"High","confidence_rationale":"Tier 1 — in vitro mutagenesis combined with kinetics and MD simulations, multiple orthogonal approaches","pmids":["29910900"],"is_preprint":false},{"year":2017,"finding":"DERA is inactivated by crotonaldehyde (a side product of acetaldehyde condensation) through formation of a covalent Michael adduct at cysteine 47 (C47) in the active site. Mutation of C47 to non-nucleophilic amino acids (e.g., C47L) confers near-complete resistance to this inhibition without loss of stereoselectivity, though a C47-independent inactivation mechanism also exists.","method":"Site-directed mutagenesis, enzyme activity assays with acetaldehyde, inhibition kinetics","journal":"Journal of biotechnology","confidence":"High","confidence_rationale":"Tier 1 — active-site mutagenesis with in vitro activity assays identifying specific covalent inhibition mechanism","pmids":["28347769"],"is_preprint":false},{"year":2018,"finding":"The C-terminal tail of E. coli DERA (residues ~251–259) is intrinsically disordered and samples both open and closed conformational states. In the closed state, the C-terminal tyrosine (Y259) enters the active site and is required for efficient proton abstraction during catalysis. Additionally, previously unknown auxiliary phosphate-binding residues on the C-terminal tail help orient Y259 for catalysis.","method":"NMR spectroscopy (NOE distance restraints, hydrogen/deuterium exchange, phosphate titration), molecular dynamics simulations, mutagenesis","journal":"ACS catalysis","confidence":"High","confidence_rationale":"Tier 1 — NMR solution structure with functional validation by H/D exchange and phosphate titration, multiple orthogonal methods","pmids":["30101036"],"is_preprint":false},{"year":2018,"finding":"DERA catalyzes stereoselective C-C bond formation between acetaldehyde and various aldehyde acceptors (including non-phosphorylated aldehydes) to yield chiral building blocks. The enzyme's tolerance to industrially relevant aldehyde concentrations is limited and can be improved by protein engineering and immobilization. The review synthesizes mechanistic understanding of aldehyde resistance and catalytic promiscuity.","method":"Review of biochemical assays, protein engineering studies, immobilization experiments","journal":"Applied microbiology and biotechnology","confidence":"Medium","confidence_rationale":"Tier 3 — comprehensive review summarizing multiple experimental studies; mechanistic details grounded in cited primary work","pmids":["30284013"],"is_preprint":false},{"year":2020,"finding":"Protein engineering of E. coli DERA active site (24 positions mutated) combined with machine learning improved acetaldehyde (C2) addition activity 2–3 fold while abolishing activity toward the natural phosphorylated donor glyceraldehyde-3-phosphate. Wild-type DERA was also shown to catalyze aldol addition using formaldehyde (C1) as donor, and some variants with improved acetaldehyde activity also showed improved formaldehyde activity.","method":"Site-directed mutagenesis, substrate activity assays, machine learning (Gaussian processes), 3D structure-guided design","journal":"Applied microbiology and biotechnology","confidence":"High","confidence_rationale":"Tier 1 — in vitro activity assays with systematic mutagenesis across multiple substrate specificities, structure-guided approach","pmids":["33147349"],"is_preprint":false}],"current_model":"Human DERA is a class I deoxyribose-5-phosphate aldolase that cleaves 2-deoxy-D-ribose-5-phosphate into glyceraldehyde-3-phosphate and acetaldehyde via a Schiff base intermediate at an active-site lysine; its intrinsically disordered C-terminal tail undergoes conformational sampling to position Y259 for proton abstraction, while anti-correlated protein motions coupled through non-canonical phosphate-binding residues (Ser238/Ser239) contribute to catalytic efficiency; in human cells DERA interacts with YBX1, localizes to stress granules under oxidative or mitochondrial stress (supporting cell survival), and enables ATP production from deoxynucleosides when mitochondrial function is impaired."},"narrative":{"teleology":[{"year":1982,"claim":"Identification of DERA as a class I aldolase using a Schiff base mechanism with an active-site lysine established the fundamental catalytic strategy of the enzyme.","evidence":"Protein purification, amino acid sequencing, and catalytic activity assays on the E. coli deoC gene product","pmids":["6749498"],"confidence":"High","gaps":["Identity of the specific lysine residue was tentative","Oligomeric state relevance to activity was not resolved","No structural model of the active site was available"]},{"year":1997,"claim":"Demonstration that DERA activity is conserved across vertebrate tissues and cell lines established its physiological role in channelling deoxyribose-5-phosphate from nucleoside catabolism into central carbon metabolism.","evidence":"Enzyme activity assays in vertebrate liver extracts and multiple mammalian cell lines","pmids":["9226884"],"confidence":"Medium","gaps":["No genetic loss-of-function validation in mammalian systems","Metabolic flux through the DERA pathway was not quantified","Regulation of DERA expression in different tissues was not addressed"]},{"year":2014,"claim":"Discovery that human DERA interacts with YBX1, localizes to stress granules under oxidative/mitochondrial stress, and supports ATP production from deoxynucleosides revealed an unexpected cell-protective role beyond housekeeping metabolism.","evidence":"Co-immunoprecipitation with YBX1, shRNA knockdown with stress granule and apoptosis readouts, ATP measurements in mitochondrially compromised cells","pmids":["25229427"],"confidence":"High","gaps":["Mechanism of DERA recruitment to stress granules is unknown","Whether enzymatic activity is required for the stress granule phenotype was not tested","The YBX1 interaction interface is uncharacterized"]},{"year":2015,"claim":"Establishing that non-canonical phosphate-binding residues Ser238/Ser239 transmit anti-correlated motions coupled to catalytic efficiency revealed how distal dynamics contribute to the retro-aldol reaction.","evidence":"Site-directed and site-saturation mutagenesis, kinetic analysis, and molecular dynamics simulations of DERA","pmids":["29910900"],"confidence":"High","gaps":["Coupling between dynamics and catalysis was inferred computationally and from temperature-dependence, not directly measured structurally","Contribution of these residues in the human enzyme was not confirmed","Role of dynamics in the forward aldol direction was not examined"]},{"year":2017,"claim":"Identification of C47 as the site of covalent inactivation by crotonaldehyde explained the long-standing vulnerability of DERA to its own product-derived inhibitor and demonstrated that mutagenesis can decouple inactivation from catalysis.","evidence":"Site-directed mutagenesis of C47 with activity and inhibition kinetics","pmids":["28347769"],"confidence":"High","gaps":["A C47-independent inactivation pathway was noted but not characterized","Structural basis of the Michael adduct was not solved crystallographically","Relevance of C47 inactivation to in vivo regulation is unknown"]},{"year":2018,"claim":"NMR characterization of the intrinsically disordered C-terminal tail showed that Y259 samples open/closed states and enters the active site for proton abstraction, resolving how a flexible element controls catalytic turnover.","evidence":"NMR spectroscopy (NOE, H/D exchange, phosphate titration) and molecular dynamics on E. coli DERA","pmids":["30101036"],"confidence":"High","gaps":["Whether the human C-terminal tail exhibits the same conformational dynamics is untested","Kinetic contribution of the open–closed equilibrium to overall rate was not quantified","No crystal structure of the closed conformation was obtained"]},{"year":2020,"claim":"Systematic active-site mutagenesis showed that donor specificity (acetaldehyde vs. glyceraldehyde-3-phosphate) can be engineered independently, and revealed a previously unrecognized native formaldehyde addition activity.","evidence":"Site-directed mutagenesis of 24 active-site positions with substrate activity assays and machine-learning guided design","pmids":["33147349"],"confidence":"High","gaps":["Physiological relevance of formaldehyde donor activity is unknown","Structural basis for the altered donor specificity was not determined","In vivo metabolic consequences of altered specificity were not tested"]},{"year":null,"claim":"Key unresolved questions include the structural basis for DERA recruitment to stress granules, whether enzymatic activity is required for the stress-protective phenotype, and the physiological significance of DERA's catalytic promiscuity in human cells.","evidence":"","pmids":[],"confidence":"Low","gaps":["No separation-of-function mutant distinguishing catalytic and stress granule roles","Human DERA crystal structure with C-terminal tail resolved is lacking","In vivo metabolic flux through the DERA pathway in human tissues has not been measured"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0016829","term_label":"lyase activity","supporting_discovery_ids":[0,1,2,3,5,7]}],"localization":[{"term_id":"GO:0005829","term_label":"cytosol","supporting_discovery_ids":[2]}],"pathway":[{"term_id":"R-HSA-1430728","term_label":"Metabolism","supporting_discovery_ids":[1,2]}],"complexes":[],"partners":["YBX1"],"other_free_text":[]},"mechanistic_narrative":"DERA is a class I deoxyribose-5-phosphate aldolase that cleaves 2-deoxy-D-ribose-5-phosphate into glyceraldehyde-3-phosphate and acetaldehyde via a Schiff base intermediate formed at an active-site lysine, channelling deoxyribose into glycolysis [PMID:6749498, PMID:9226884]. Catalytic efficiency depends on anti-correlated protein dynamics coupled through non-canonical phosphate-binding residues (Ser238/Ser239) and on an intrinsically disordered C-terminal tail whose terminal tyrosine (Y259) samples open and closed conformations to position itself for proton abstraction in the active site [PMID:29910900, PMID:30101036]. In human cells, DERA interacts with YBX1 and is recruited to stress granules under oxidative or mitochondrial stress, where it promotes stress granule formation and cell survival; DERA also enables ATP production from extracellular deoxynucleosides when mitochondrial function is impaired [PMID:25229427]. The enzyme is subject to covalent inactivation by crotonaldehyde at active-site residue C47, a vulnerability that can be abolished by mutagenesis without loss of stereoselectivity [PMID:28347769]."},"prefetch_data":{"uniprot":{"accession":"Q9Y315","full_name":"Deoxyribose-phosphate aldolase","aliases":["2-deoxy-D-ribose 5-phosphate aldolase","Phosphodeoxyriboaldolase","Deoxyriboaldolase"],"length_aa":318,"mass_kda":35.2,"function":"Catalyzes a reversible aldol reaction between acetaldehyde and D-glyceraldehyde 3-phosphate to generate 2-deoxy-D-ribose 5-phosphate. Participates in stress granule (SG) assembly. May allow ATP production from extracellular deoxyinosine in conditions of energy deprivation","subcellular_location":"Cytoplasm; Cytoplasmic granule; Nucleus","url":"https://www.uniprot.org/uniprotkb/Q9Y315/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/DERA","classification":"Not Classified","n_dependent_lines":1,"n_total_lines":1208,"dependency_fraction":0.0008278145695364238},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[{"gene":"ALDH16A1","stoichiometry":10.0}],"url":"https://opencell.sf.czbiohub.org/search/DERA","total_profiled":1310},"omim":[{"mim_id":"619668","title":"DEOXYRIBOSE-PHOSPHATE ALDOLASE; DERA","url":"https://www.omim.org/entry/619668"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Supported","locations":[{"location":"Nucleoplasm","reliability":"Supported"}],"tissue_specificity":"Tissue enhanced","tissue_distribution":"Detected in all","driving_tissues":[{"tissue":"liver","ntpm":97.7}],"url":"https://www.proteinatlas.org/search/DERA"},"hgnc":{"alias_symbol":["CGI-26","DEOC"],"prev_symbol":[]},"alphafold":{"accession":"Q9Y315","domains":[{"cath_id":"3.20.20.70","chopping":"22-315","consensus_level":"medium","plddt":96.9698,"start":22,"end":315}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q9Y315","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q9Y315-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q9Y315-F1-predicted_aligned_error_v6.png","plddt_mean":96.0},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=DERA","jax_strain_url":"https://www.jax.org/strain/search?query=DERA"},"sequence":{"accession":"Q9Y315","fasta_url":"https://rest.uniprot.org/uniprotkb/Q9Y315.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q9Y315/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q9Y315"}},"corpus_meta":[{"pmid":"6749498","id":"PMC_6749498","title":"The primary structure of Escherichia coli K12 2-deoxyribose 5-phosphate aldolase. Nucleotide sequence of the deoC gene and the amino acid sequence of the enzyme.","date":"1982","source":"European journal of biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/6749498","citation_count":45,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"6323164","id":"PMC_6323164","title":"Structure and function of the intercistronic regulatory deoC-deoA element of Escherichia coli K-12.","date":"1984","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/6323164","citation_count":33,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"30284013","id":"PMC_30284013","title":"2-Deoxy-D-ribose-5-phosphate aldolase (DERA): applications and modifications.","date":"2018","source":"Applied microbiology and biotechnology","url":"https://pubmed.ncbi.nlm.nih.gov/30284013","citation_count":29,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"25229427","id":"PMC_25229427","title":"DERA is the human deoxyribose phosphate aldolase and is involved in stress response.","date":"2014","source":"Biochimica et biophysica acta","url":"https://pubmed.ncbi.nlm.nih.gov/25229427","citation_count":25,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"33147349","id":"PMC_33147349","title":"Substrate specificity of 2-deoxy-D-ribose 5-phosphate aldolase (DERA) assessed by different protein engineering and machine learning methods.","date":"2020","source":"Applied microbiology and biotechnology","url":"https://pubmed.ncbi.nlm.nih.gov/33147349","citation_count":19,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"23667462","id":"PMC_23667462","title":"A highly productive, whole-cell DERA chemoenzymatic process for production of key lactonized side-chain intermediates in statin synthesis.","date":"2013","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/23667462","citation_count":17,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"30101036","id":"PMC_30101036","title":"Conformational Sampling of the Intrinsically Disordered C-Terminal Tail of DERA Is Important for Enzyme Catalysis.","date":"2018","source":"ACS catalysis","url":"https://pubmed.ncbi.nlm.nih.gov/30101036","citation_count":13,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"28347769","id":"PMC_28347769","title":"Probing the acetaldehyde-sensitivity of 2-deoxy-ribose-5-phosphate aldolase (DERA) leads to resistant variants.","date":"2017","source":"Journal of biotechnology","url":"https://pubmed.ncbi.nlm.nih.gov/28347769","citation_count":11,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"31738478","id":"PMC_31738478","title":"Seed morphology using SEM techniques for identification of useful grasses in Dera Ghazi Khan, Pakistan.","date":"2019","source":"Microscopy research and technique","url":"https://pubmed.ncbi.nlm.nih.gov/31738478","citation_count":10,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"20229283","id":"PMC_20229283","title":"The fed-batch production of a thermophilic 2-deoxyribose-5-phosphate aldolase (DERA) in Escherichia coli by exponential feeding strategy control.","date":"2010","source":"Applied biochemistry and biotechnology","url":"https://pubmed.ncbi.nlm.nih.gov/20229283","citation_count":10,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"29910900","id":"PMC_29910900","title":"Linking coupled motions and entropic effects to the catalytic activity of 2-deoxyribose-5-phosphate aldolase (DERA).","date":"2015","source":"Chemical science","url":"https://pubmed.ncbi.nlm.nih.gov/29910900","citation_count":9,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"33579093","id":"PMC_33579093","title":"A report on the molecular detection and seasonal prevalence of Trypanosoma brucei in Dromedary Camels from Dera Ghazi Khan District in Southern Punjab (Pakistan).","date":"2016","source":"Tropical biomedicine","url":"https://pubmed.ncbi.nlm.nih.gov/33579093","citation_count":6,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"32659474","id":"PMC_32659474","title":"Genetic variants in TKT and DERA in the nicotinamide adenine dinucleotide phosphate pathway predict melanoma survival.","date":"2020","source":"European journal of cancer (Oxford, England : 1990)","url":"https://pubmed.ncbi.nlm.nih.gov/32659474","citation_count":5,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"14612251","id":"PMC_14612251","title":"Mutations in deoB and deoC alter an extracellular signaling pathway required for activation of the gab operon in Escherichia coli.","date":"2003","source":"FEMS microbiology letters","url":"https://pubmed.ncbi.nlm.nih.gov/14612251","citation_count":4,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"17547717","id":"PMC_17547717","title":"Establishment and characterization of a cell line (DEOC-1) originating from a human malignant melanoma of the skin.","date":"2007","source":"Human cell","url":"https://pubmed.ncbi.nlm.nih.gov/17547717","citation_count":3,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"37750990","id":"PMC_37750990","title":"Genomic selection pressure discovery using site-frequency spectrum and reduced local variability statistics in Pakistani Dera-Din-Panah goat.","date":"2023","source":"Tropical animal health and production","url":"https://pubmed.ncbi.nlm.nih.gov/37750990","citation_count":3,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"33159762","id":"PMC_33159762","title":"Haematological outcomes in progression of malaria: A cohort study from district Dera Ismail Khan, Pakistan.","date":"2020","source":"JPMA. The Journal of the Pakistan Medical Association","url":"https://pubmed.ncbi.nlm.nih.gov/33159762","citation_count":3,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"37491848","id":"PMC_37491848","title":"Genetic basis of ß-thalassemia in families of pashtun ethnicity in Dera Ismail Khan district of Khyber Pakhtun-Khwa province, Pakistan.","date":"2023","source":"Expert review of hematology","url":"https://pubmed.ncbi.nlm.nih.gov/37491848","citation_count":1,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"24696983","id":"PMC_24696983","title":"Characterization of the etiological agents of tuberculous lymphadenitis in Dera Woreda, North Showa, Ethiopia.","date":"2014","source":"Ethiopian medical journal","url":"https://pubmed.ncbi.nlm.nih.gov/24696983","citation_count":1,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"40895961","id":"PMC_40895961","title":"Epidemiological Study of Dengue Fever in a Tertiary Care Hospital in Dera Ismail Khan, Pakistan.","date":"2025","source":"Cureus","url":"https://pubmed.ncbi.nlm.nih.gov/40895961","citation_count":0,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"40509167","id":"PMC_40509167","title":"Flow Synthesis of Pharmaceutical Intermediate Catalyzed by Immobilized DERA: Comparison of Different Immobilization Techniques and Reactor Designs.","date":"2025","source":"Molecules (Basel, Switzerland)","url":"https://pubmed.ncbi.nlm.nih.gov/40509167","citation_count":0,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":null,"id":"bio_10.1101_2025.07.22.666072","title":"Construction of a genome-wide pooled CRISPRi library as a resource for exploring the acid tolerance mechanism in <i>Streptococcus mutans</i>","date":"2025-07-22","source":"bioRxiv","url":"https://doi.org/10.1101/2025.07.22.666072","citation_count":0,"is_preprint":true,"source_track":"pubmed_title"},{"pmid":"12477932","id":"PMC_12477932","title":"Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences.","date":"2002","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/12477932","citation_count":1479,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"26186194","id":"PMC_26186194","title":"The BioPlex Network: A Systematic Exploration of the Human Interactome.","date":"2015","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/26186194","citation_count":1118,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"28514442","id":"PMC_28514442","title":"Architecture of the human interactome defines protein communities and disease networks.","date":"2017","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/28514442","citation_count":1085,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"26496610","id":"PMC_26496610","title":"A human interactome in three quantitative dimensions organized by stoichiometries and abundances.","date":"2015","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/26496610","citation_count":1015,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"32296183","id":"PMC_32296183","title":"A reference map of the human binary protein interactome.","date":"2020","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/32296183","citation_count":849,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"17353931","id":"PMC_17353931","title":"Large-scale mapping of human protein-protein interactions by mass spectrometry.","date":"2007","source":"Molecular systems biology","url":"https://pubmed.ncbi.nlm.nih.gov/17353931","citation_count":733,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"33961781","id":"PMC_33961781","title":"Dual proteome-scale networks reveal cell-specific remodeling of the human interactome.","date":"2021","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/33961781","citation_count":705,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"22939629","id":"PMC_22939629","title":"A census of human soluble protein complexes.","date":"2012","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/22939629","citation_count":689,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"21873635","id":"PMC_21873635","title":"Phylogenetic-based propagation of functional annotations within the Gene Ontology consortium.","date":"2011","source":"Briefings in bioinformatics","url":"https://pubmed.ncbi.nlm.nih.gov/21873635","citation_count":656,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"8125298","id":"PMC_8125298","title":"Oligo-capping: a simple method to replace the cap structure of eukaryotic mRNAs with oligoribonucleotides.","date":"1994","source":"Gene","url":"https://pubmed.ncbi.nlm.nih.gov/8125298","citation_count":492,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"35271311","id":"PMC_35271311","title":"OpenCell: Endogenous tagging for the cartography of human cellular organization.","date":"2022","source":"Science (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/35271311","citation_count":432,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"26344197","id":"PMC_26344197","title":"Panorama of ancient metazoan macromolecular complexes.","date":"2015","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/26344197","citation_count":407,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"8889548","id":"PMC_8889548","title":"Normalization and subtraction: two approaches to facilitate gene discovery.","date":"1996","source":"Genome research","url":"https://pubmed.ncbi.nlm.nih.gov/8889548","citation_count":401,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"10810093","id":"PMC_10810093","title":"Identification of novel human genes evolutionarily conserved in Caenorhabditis elegans by comparative proteomics.","date":"2000","source":"Genome research","url":"https://pubmed.ncbi.nlm.nih.gov/10810093","citation_count":392,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"22863883","id":"PMC_22863883","title":"A high-throughput approach for measuring temporal changes in the interactome.","date":"2012","source":"Nature methods","url":"https://pubmed.ncbi.nlm.nih.gov/22863883","citation_count":273,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"12546782","id":"PMC_12546782","title":"Phylogenetic analyses of diplomonad genes reveal frequent lateral gene transfers affecting eukaryotes.","date":"2003","source":"Current biology : CB","url":"https://pubmed.ncbi.nlm.nih.gov/12546782","citation_count":145,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"23376485","id":"PMC_23376485","title":"Proteomic analysis of podocyte exosome-enriched fraction from normal human urine.","date":"2013","source":"Journal of proteomics","url":"https://pubmed.ncbi.nlm.nih.gov/23376485","citation_count":126,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"20379614","id":"PMC_20379614","title":"Personalized smoking cessation: interactions between nicotine dose, dependence and quit-success genotype score.","date":"2010","source":"Molecular medicine (Cambridge, Mass.)","url":"https://pubmed.ncbi.nlm.nih.gov/20379614","citation_count":108,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"33545068","id":"PMC_33545068","title":"Systematically defining selective autophagy receptor-specific cargo using autophagosome content profiling.","date":"2021","source":"Molecular cell","url":"https://pubmed.ncbi.nlm.nih.gov/33545068","citation_count":105,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"35256949","id":"PMC_35256949","title":"Histone deacetylase inhibitors inhibit cervical cancer growth through Parkin acetylation-mediated mitophagy.","date":"2021","source":"Acta pharmaceutica Sinica. B","url":"https://pubmed.ncbi.nlm.nih.gov/35256949","citation_count":66,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"35831314","id":"PMC_35831314","title":"Scalable multiplex co-fractionation/mass spectrometry platform for accelerated protein interactome discovery.","date":"2022","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/35831314","citation_count":65,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"36138187","id":"PMC_36138187","title":"NUDT21 limits CD19 levels through alternative mRNA polyadenylation in B cell acute lymphoblastic leukemia.","date":"2022","source":"Nature immunology","url":"https://pubmed.ncbi.nlm.nih.gov/36138187","citation_count":46,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"37054706","id":"PMC_37054706","title":"ATG5 provides host protection acting as a switch in the atg8ylation cascade between autophagy and secretion.","date":"2023","source":"Developmental cell","url":"https://pubmed.ncbi.nlm.nih.gov/37054706","citation_count":46,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"34578187","id":"PMC_34578187","title":"Interactome Analysis of the Nucleocapsid Protein of SARS-CoV-2 Virus.","date":"2021","source":"Pathogens (Basel, Switzerland)","url":"https://pubmed.ncbi.nlm.nih.gov/34578187","citation_count":32,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"36168628","id":"PMC_36168628","title":"The N6-methyladenosine-mediated lncRNA WEE2-AS1 promotes glioblastoma progression by stabilizing RPN2.","date":"2022","source":"Theranostics","url":"https://pubmed.ncbi.nlm.nih.gov/36168628","citation_count":32,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"31067453","id":"PMC_31067453","title":"CYLD Regulates Centriolar Satellites Proteostasis by Counteracting the E3 Ligase MIB1.","date":"2019","source":"Cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/31067453","citation_count":28,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"36215168","id":"PMC_36215168","title":"TRIM67 drives tumorigenesis in oligodendrogliomas through Rho GTPase-dependent membrane blebbing.","date":"2023","source":"Neuro-oncology","url":"https://pubmed.ncbi.nlm.nih.gov/36215168","citation_count":25,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"9226884","id":"PMC_9226884","title":"Channelling of deoxyribose moiety of exogenous DNA into carbohydrate metabolism: role of deoxyriboaldolase.","date":"1997","source":"Comparative biochemistry and physiology. Part B, Biochemistry & molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/9226884","citation_count":24,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"37827155","id":"PMC_37827155","title":"Antagonistic roles of canonical and Alternative-RPA in disease-associated tandem CAG repeat instability.","date":"2023","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/37827155","citation_count":23,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"40140646","id":"PMC_40140646","title":"Combined targeting of glioblastoma stem cells of different cellular states disrupts malignant progression.","date":"2025","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/40140646","citation_count":21,"is_preprint":false,"source_track":"gene2pubmed"}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":12119,"output_tokens":1660,"usd":0.030628},"stage2":{"model":"claude-opus-4-6","input_tokens":4899,"output_tokens":1786,"usd":0.103718},"total_usd":0.303424,"stage1_batch_id":"msgbatch_0118RScg3WGaGkaZRtWZbtce","stage2_batch_id":"msgbatch_01Cpfzvtbj42aqp5oYZ5Te2s","note":"batch pricing = 50% of standard","round2_stage1":{"model":"claude-sonnet-4-6","input_tokens":24489,"output_tokens":2128,"usd":0.052693},"round2_rules_fired":"R3","round2_stage2":{"model":"claude-opus-4-6","input_tokens":5643,"output_tokens":1975,"usd":0.116385}},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1982,\n      \"finding\": \"E. coli DERA (deoC gene product) is a class I aldolase consisting of 259 amino acids that forms Schiff base intermediates with substrate; a lysine residue in the active site was tentatively identified as the catalytic residue involved in Schiff base formation.\",\n      \"method\": \"Protein sequencing, amino acid composition analysis, catalytic property characterization\",\n      \"journal\": \"European journal of biochemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 — biochemical characterization with sequence data, single lab, active-site residue tentatively identified\",\n      \"pmids\": [\"6749498\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"Human DERA protein is the deoxyribose phosphate aldolase responsible for converting 2-deoxy-d-ribose-5-phosphate into glyceraldehyde-3-phosphate and acetaldehyde; DERA interacts with the stress granule component YBX1 and is recruited to stress granules after oxidative or mitochondrial stress; shRNA knockdown of DERA reduces stress granule formation and increases susceptibility to apoptosis after clotrimazole stress; DERA expression enables cells with abolished mitochondrial ATP production to use extracellular deoxyinosine to maintain ATP levels via nucleoside degradation.\",\n      \"method\": \"Enzymatic activity assays, Co-immunoprecipitation with YBX1, shRNA knockdown with stress granule imaging and apoptosis readout, ATP maintenance assay\",\n      \"journal\": \"Biochimica et biophysica acta\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal methods (enzymatic assay, Co-IP, KD with defined cellular phenotype, metabolic rescue assay) in single lab\",\n      \"pmids\": [\"25229427\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"The intrinsically disordered C-terminal tail of E. coli DERA (residues ~251–259) exists in equilibrium between open and closed states; the C-terminal tyrosine Y259 enters the active site in the closed state and is required for the proton abstraction step of catalysis; auxiliary phosphate-binding residues on the C-terminal tail help orient Y259 for catalysis.\",\n      \"method\": \"NMR spectroscopy (NOE distance restraints, H/D exchange), molecular dynamics simulations, phosphate titration experiments, solution-state structure determination\",\n      \"journal\": \"ACS catalysis\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — NMR structure determination with functional validation via H/D exchange kinetics, replicated by MD simulations\",\n      \"pmids\": [\"30101036\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"The non-canonical phosphate-binding site of DERA (Ser238 and Ser239) contributes to catalytic efficiency via anticorrelated protein motions distributed over the entire enzyme; the S239P mutant shows increased enthalpy at the transition state but loss of conformational entropy and anticorrelated dynamics, reducing catalytic efficiency in the retro-aldol cleavage reaction.\",\n      \"method\": \"Site-directed and site-saturation mutagenesis, kinetic analysis, molecular dynamics simulations, temperature-dependence of catalytic rates\",\n      \"journal\": \"Chemical science\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — in vitro mutagenesis combined with kinetic assays and MD simulations; multiple orthogonal methods\",\n      \"pmids\": [\"29910900\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"Crotonaldehyde (a side-product generated from acetaldehyde by DERA) irreversibly inhibits DERA by forming a covalent Michael-adduct at cysteine 47 (C47) in the active site; mutating C47 to non-nucleophilic amino acids (e.g., C47L) eliminates this inhibition pathway without loss of stereoselectivity, though a C47-independent inactivation mechanism also exists.\",\n      \"method\": \"Active-site mutagenesis, activity assays with acetaldehyde, characterization of covalent inhibitor adduct\",\n      \"journal\": \"Journal of biotechnology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 — mutagenesis with in vitro activity assays; single lab but direct mechanistic result\",\n      \"pmids\": [\"28347769\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"E. coli DERA active-site and near-active-site residue mutations (at 24 positions) alter substrate specificity; engineering led to 2–3-fold improved activity toward acetaldehyde (C2) as donor and abolished activity toward phosphorylated glyceraldehyde-3-phosphate; DERA wild-type can also use formaldehyde (C1) as a donor substrate.\",\n      \"method\": \"Site-directed mutagenesis, in vitro enzymatic activity assays with multiple substrates, machine learning-guided mutagenesis, 3D crystal structure-guided design\",\n      \"journal\": \"Applied microbiology and biotechnology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 — structure-guided mutagenesis with quantitative activity assays; single lab\",\n      \"pmids\": [\"33147349\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"Human DERA is a class I aldolase that catalyzes reversible retro-aldol cleavage of 2-deoxy-d-ribose-5-phosphate into glyceraldehyde-3-phosphate and acetaldehyde via a Schiff base intermediate at an active-site lysine; catalysis requires proton abstraction facilitated by the intrinsically disordered C-terminal tyrosine (Y259) entering the active site, and is coupled to anticorrelated protein dynamics at a non-canonical phosphate-binding site (Ser238/Ser239); irreversible inhibition by crotonaldehyde occurs via a covalent Michael-adduct at Cys47; in human cells DERA interacts with YBX1, localizes to stress granules under oxidative or mitochondrial stress, promotes stress granule formation, and enables use of extracellular deoxyinosine for ATP production when mitochondrial function is impaired.\"\n}\n```\n\n--- ROUND 2 (R2/R3, augmented corpus) ---\n\n```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1982,\n      \"finding\": \"DERA (deoC gene product) is a class I aldolase of 259 amino acids (MW ~27,737) that forms Schiff base intermediates during catalysis. The enzyme can exist as both a monomer and dimer, and a lysine residue in the active site was tentatively identified as the catalytic nucleophile involved in Schiff base formation.\",\n      \"method\": \"Protein purification, amino acid sequencing, nucleotide sequencing, catalytic activity assays\",\n      \"journal\": \"European journal of biochemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — direct biochemical characterization with sequence determination and active-site identification\",\n      \"pmids\": [\"6749498\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1997,\n      \"finding\": \"Deoxyriboaldolase (DERA) activity is present in liver of several vertebrates and in multiple cell lines, enabling channelling of deoxyribose-5-phosphate (derived from exogenous DNA or deoxynucleosides) into glycolysis. In Bacillus cereus, switching to anaerobic conditions further increased DERA activity, enhancing deoxyribose utilization as a carbon/energy source.\",\n      \"method\": \"Enzyme activity assays in cell lines and vertebrate liver extracts; bacterial induction experiments under aerobic/anaerobic conditions\",\n      \"journal\": \"Comparative biochemistry and physiology. Part B, Biochemistry & molecular biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — multiple cell lines/tissues tested, but no mutagenesis or structural validation\",\n      \"pmids\": [\"9226884\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"Human DERA is the deoxyribose phosphate aldolase that converts 2-deoxy-D-ribose-5-phosphate into glyceraldehyde-3-phosphate and acetaldehyde. DERA interacts with the stress granule component YBX1 and is recruited to stress granules upon oxidative or mitochondrial stress. shRNA-mediated knockdown of DERA reduced stress granule formation and increased apoptosis after clotrimazole stress. Additionally, DERA expression enables cells with abolished mitochondrial ATP production to use extracellular deoxyinosine to maintain ATP levels via deoxynucleoside degradation.\",\n      \"method\": \"shRNA knockdown, deoxyribose phosphate aldolase activity assays, co-immunoprecipitation with YBX1, immunofluorescence of stress granules, ATP level measurements\",\n      \"journal\": \"Biochimica et biophysica acta\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal methods: enzymatic assay, Co-IP, KD with defined phenotypic readouts\",\n      \"pmids\": [\"25229427\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"The non-canonical phosphate-binding site of DERA (residues Ser238 and Ser239) contributes to catalytic efficiency through coupled protein dynamics. The S239P mutant showed increased enthalpy but decreased entropy at the transition state, with a concomitant loss of anti-correlated motions across the protein. These anti-correlated motions are coupled to catalytic efficiency in the retro-aldol cleavage reaction.\",\n      \"method\": \"Site-directed mutagenesis, site-saturation mutagenesis, kinetic analysis, molecular dynamics simulations, temperature-dependence of catalytic rates\",\n      \"journal\": \"Chemical science\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — in vitro mutagenesis combined with kinetics and MD simulations, multiple orthogonal approaches\",\n      \"pmids\": [\"29910900\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"DERA is inactivated by crotonaldehyde (a side product of acetaldehyde condensation) through formation of a covalent Michael adduct at cysteine 47 (C47) in the active site. Mutation of C47 to non-nucleophilic amino acids (e.g., C47L) confers near-complete resistance to this inhibition without loss of stereoselectivity, though a C47-independent inactivation mechanism also exists.\",\n      \"method\": \"Site-directed mutagenesis, enzyme activity assays with acetaldehyde, inhibition kinetics\",\n      \"journal\": \"Journal of biotechnology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — active-site mutagenesis with in vitro activity assays identifying specific covalent inhibition mechanism\",\n      \"pmids\": [\"28347769\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"The C-terminal tail of E. coli DERA (residues ~251–259) is intrinsically disordered and samples both open and closed conformational states. In the closed state, the C-terminal tyrosine (Y259) enters the active site and is required for efficient proton abstraction during catalysis. Additionally, previously unknown auxiliary phosphate-binding residues on the C-terminal tail help orient Y259 for catalysis.\",\n      \"method\": \"NMR spectroscopy (NOE distance restraints, hydrogen/deuterium exchange, phosphate titration), molecular dynamics simulations, mutagenesis\",\n      \"journal\": \"ACS catalysis\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — NMR solution structure with functional validation by H/D exchange and phosphate titration, multiple orthogonal methods\",\n      \"pmids\": [\"30101036\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"DERA catalyzes stereoselective C-C bond formation between acetaldehyde and various aldehyde acceptors (including non-phosphorylated aldehydes) to yield chiral building blocks. The enzyme's tolerance to industrially relevant aldehyde concentrations is limited and can be improved by protein engineering and immobilization. The review synthesizes mechanistic understanding of aldehyde resistance and catalytic promiscuity.\",\n      \"method\": \"Review of biochemical assays, protein engineering studies, immobilization experiments\",\n      \"journal\": \"Applied microbiology and biotechnology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 — comprehensive review summarizing multiple experimental studies; mechanistic details grounded in cited primary work\",\n      \"pmids\": [\"30284013\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"Protein engineering of E. coli DERA active site (24 positions mutated) combined with machine learning improved acetaldehyde (C2) addition activity 2–3 fold while abolishing activity toward the natural phosphorylated donor glyceraldehyde-3-phosphate. Wild-type DERA was also shown to catalyze aldol addition using formaldehyde (C1) as donor, and some variants with improved acetaldehyde activity also showed improved formaldehyde activity.\",\n      \"method\": \"Site-directed mutagenesis, substrate activity assays, machine learning (Gaussian processes), 3D structure-guided design\",\n      \"journal\": \"Applied microbiology and biotechnology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — in vitro activity assays with systematic mutagenesis across multiple substrate specificities, structure-guided approach\",\n      \"pmids\": [\"33147349\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"Human DERA is a class I deoxyribose-5-phosphate aldolase that cleaves 2-deoxy-D-ribose-5-phosphate into glyceraldehyde-3-phosphate and acetaldehyde via a Schiff base intermediate at an active-site lysine; its intrinsically disordered C-terminal tail undergoes conformational sampling to position Y259 for proton abstraction, while anti-correlated protein motions coupled through non-canonical phosphate-binding residues (Ser238/Ser239) contribute to catalytic efficiency; in human cells DERA interacts with YBX1, localizes to stress granules under oxidative or mitochondrial stress (supporting cell survival), and enables ATP production from deoxynucleosides when mitochondrial function is impaired.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"DERA is a class I aldolase that catalyzes the reversible retro-aldol cleavage of 2-deoxy-D-ribose-5-phosphate into glyceraldehyde-3-phosphate and acetaldehyde, proceeding through a Schiff base intermediate at an active-site lysine [PMID:6749498, PMID:25229427]. Catalytic efficiency depends on the intrinsically disordered C-terminal tail, whose terminal tyrosine (Y259) enters the active site in a closed conformation to facilitate proton abstraction, and on anticorrelated protein dynamics at the non-canonical phosphate-binding site (Ser238/Ser239) that contribute conformational entropy to transition-state stabilization [PMID:30101036, PMID:29910900]. The enzyme is susceptible to irreversible inhibition by crotonaldehyde via a covalent Michael adduct at Cys47 [PMID:28347769]. In human cells, DERA interacts with YBX1, localizes to stress granules under oxidative or mitochondrial stress to promote their formation and protect against apoptosis, and enables ATP production from extracellular deoxyinosine when mitochondrial function is compromised [PMID:25229427].\",\n  \"teleology\": [\n    {\n      \"year\": 1982,\n      \"claim\": \"Establishing DERA as a class I aldolase that forms a covalent Schiff base intermediate with substrate answered how the enzyme activates deoxyribose-5-phosphate cleavage and identified an active-site lysine as the catalytic nucleophile.\",\n      \"evidence\": \"Protein sequencing and catalytic characterization of E. coli deoC gene product\",\n      \"pmids\": [\"6749498\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Active-site lysine was tentatively identified; definitive mutagenesis confirmation was lacking\",\n        \"No structural model of the active site available\",\n        \"Human ortholog not yet characterized\"\n      ]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Demonstrating that human DERA performs deoxyribose phosphate aldolase activity, interacts with YBX1 at stress granules, promotes stress granule assembly, and enables deoxyinosine-dependent ATP production established DERA as a metabolic enzyme with a non-catalytic cytoprotective role during mitochondrial or oxidative stress.\",\n      \"evidence\": \"Enzymatic assays, Co-IP with YBX1, shRNA knockdown with stress granule imaging and apoptosis readout, ATP maintenance assay in human cells\",\n      \"pmids\": [\"25229427\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Mechanism by which DERA is recruited to stress granules is unknown\",\n        \"Whether the aldolase catalytic activity is required for stress granule function was not tested\",\n        \"Physiological relevance of deoxyinosine rescue pathway in vivo not established\"\n      ]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Revealing that the non-canonical phosphate-binding site (Ser238/Ser239) drives catalytic efficiency through anticorrelated protein dynamics and conformational entropy explained how residues distant from the active site tune DERA's transition-state energetics.\",\n      \"evidence\": \"Site-directed mutagenesis with kinetic analysis, temperature-dependence studies, and molecular dynamics simulations on E. coli DERA\",\n      \"pmids\": [\"29910900\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Contribution of these dynamics in the human enzyme not directly measured\",\n        \"Whether anticorrelated motions affect the aldol synthesis direction similarly is untested\"\n      ]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Identifying Cys47 as the site of irreversible covalent inhibition by crotonaldehyde via Michael addition explained a major mechanism of product-mediated enzyme inactivation and showed it could be engineered out without loss of stereoselectivity.\",\n      \"evidence\": \"Active-site mutagenesis (C47L and others) with activity assays and inhibitor characterization\",\n      \"pmids\": [\"28347769\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"A second, C47-independent inactivation pathway was noted but not characterized\",\n        \"Physiological relevance of crotonaldehyde inhibition in human cells not examined\"\n      ]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Solving the conformational dynamics of DERA's disordered C-terminal tail by NMR and showing that Y259 must enter the active site for proton abstraction revealed the catalytic role of an intrinsically disordered region in substrate turnover.\",\n      \"evidence\": \"NMR spectroscopy (NOE, H/D exchange), molecular dynamics simulations on E. coli DERA\",\n      \"pmids\": [\"30101036\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Structural basis of how Y259 positioning is coupled to product release is unresolved\",\n        \"Whether the human C-terminal tail behaves identically has not been confirmed by NMR\"\n      ]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Systematic active-site mutagenesis demonstrated that DERA's substrate scope extends to formaldehyde as donor and can be engineered for altered donor/acceptor specificity, refining understanding of how active-site geometry dictates substrate selectivity.\",\n      \"evidence\": \"Structure-guided and machine learning-guided mutagenesis with in vitro multi-substrate activity assays on E. coli DERA\",\n      \"pmids\": [\"33147349\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Formaldehyde utilization was shown in vitro; physiological relevance unknown\",\n        \"Structural basis for engineered specificity changes not resolved crystallographically\"\n      ]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"The mechanism by which DERA is recruited to stress granules, whether its catalytic activity is required for stress granule function, and the structural basis of DERA-YBX1 interaction remain unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"No separation-of-function mutant distinguishing catalytic vs. stress granule roles\",\n        \"No structural model of the DERA–YBX1 complex\",\n        \"In vivo metabolic flux through DERA in stressed human tissues not measured\"\n      ]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0016829\", \"supporting_discovery_ids\": [0, 1, 2, 3, 5]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005829\", \"supporting_discovery_ids\": [1]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-1430728\", \"supporting_discovery_ids\": [1, 5]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\"YBX1\"],\n    \"other_free_text\": []\n  }\n}\n```\n\n--- ROUND 2 (R2/R3, augmented corpus) ---\n\n```json\n{\n  \"mechanistic_narrative\": \"DERA is a class I deoxyribose-5-phosphate aldolase that cleaves 2-deoxy-D-ribose-5-phosphate into glyceraldehyde-3-phosphate and acetaldehyde via a Schiff base intermediate formed at an active-site lysine, channelling deoxyribose into glycolysis [PMID:6749498, PMID:9226884]. Catalytic efficiency depends on anti-correlated protein dynamics coupled through non-canonical phosphate-binding residues (Ser238/Ser239) and on an intrinsically disordered C-terminal tail whose terminal tyrosine (Y259) samples open and closed conformations to position itself for proton abstraction in the active site [PMID:29910900, PMID:30101036]. In human cells, DERA interacts with YBX1 and is recruited to stress granules under oxidative or mitochondrial stress, where it promotes stress granule formation and cell survival; DERA also enables ATP production from extracellular deoxynucleosides when mitochondrial function is impaired [PMID:25229427]. The enzyme is subject to covalent inactivation by crotonaldehyde at active-site residue C47, a vulnerability that can be abolished by mutagenesis without loss of stereoselectivity [PMID:28347769].\",\n  \"teleology\": [\n    {\n      \"year\": 1982,\n      \"claim\": \"Identification of DERA as a class I aldolase using a Schiff base mechanism with an active-site lysine established the fundamental catalytic strategy of the enzyme.\",\n      \"evidence\": \"Protein purification, amino acid sequencing, and catalytic activity assays on the E. coli deoC gene product\",\n      \"pmids\": [\"6749498\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Identity of the specific lysine residue was tentative\",\n        \"Oligomeric state relevance to activity was not resolved\",\n        \"No structural model of the active site was available\"\n      ]\n    },\n    {\n      \"year\": 1997,\n      \"claim\": \"Demonstration that DERA activity is conserved across vertebrate tissues and cell lines established its physiological role in channelling deoxyribose-5-phosphate from nucleoside catabolism into central carbon metabolism.\",\n      \"evidence\": \"Enzyme activity assays in vertebrate liver extracts and multiple mammalian cell lines\",\n      \"pmids\": [\"9226884\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"No genetic loss-of-function validation in mammalian systems\",\n        \"Metabolic flux through the DERA pathway was not quantified\",\n        \"Regulation of DERA expression in different tissues was not addressed\"\n      ]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Discovery that human DERA interacts with YBX1, localizes to stress granules under oxidative/mitochondrial stress, and supports ATP production from deoxynucleosides revealed an unexpected cell-protective role beyond housekeeping metabolism.\",\n      \"evidence\": \"Co-immunoprecipitation with YBX1, shRNA knockdown with stress granule and apoptosis readouts, ATP measurements in mitochondrially compromised cells\",\n      \"pmids\": [\"25229427\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Mechanism of DERA recruitment to stress granules is unknown\",\n        \"Whether enzymatic activity is required for the stress granule phenotype was not tested\",\n        \"The YBX1 interaction interface is uncharacterized\"\n      ]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Establishing that non-canonical phosphate-binding residues Ser238/Ser239 transmit anti-correlated motions coupled to catalytic efficiency revealed how distal dynamics contribute to the retro-aldol reaction.\",\n      \"evidence\": \"Site-directed and site-saturation mutagenesis, kinetic analysis, and molecular dynamics simulations of DERA\",\n      \"pmids\": [\"29910900\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Coupling between dynamics and catalysis was inferred computationally and from temperature-dependence, not directly measured structurally\",\n        \"Contribution of these residues in the human enzyme was not confirmed\",\n        \"Role of dynamics in the forward aldol direction was not examined\"\n      ]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Identification of C47 as the site of covalent inactivation by crotonaldehyde explained the long-standing vulnerability of DERA to its own product-derived inhibitor and demonstrated that mutagenesis can decouple inactivation from catalysis.\",\n      \"evidence\": \"Site-directed mutagenesis of C47 with activity and inhibition kinetics\",\n      \"pmids\": [\"28347769\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"A C47-independent inactivation pathway was noted but not characterized\",\n        \"Structural basis of the Michael adduct was not solved crystallographically\",\n        \"Relevance of C47 inactivation to in vivo regulation is unknown\"\n      ]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"NMR characterization of the intrinsically disordered C-terminal tail showed that Y259 samples open/closed states and enters the active site for proton abstraction, resolving how a flexible element controls catalytic turnover.\",\n      \"evidence\": \"NMR spectroscopy (NOE, H/D exchange, phosphate titration) and molecular dynamics on E. coli DERA\",\n      \"pmids\": [\"30101036\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Whether the human C-terminal tail exhibits the same conformational dynamics is untested\",\n        \"Kinetic contribution of the open–closed equilibrium to overall rate was not quantified\",\n        \"No crystal structure of the closed conformation was obtained\"\n      ]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Systematic active-site mutagenesis showed that donor specificity (acetaldehyde vs. glyceraldehyde-3-phosphate) can be engineered independently, and revealed a previously unrecognized native formaldehyde addition activity.\",\n      \"evidence\": \"Site-directed mutagenesis of 24 active-site positions with substrate activity assays and machine-learning guided design\",\n      \"pmids\": [\"33147349\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Physiological relevance of formaldehyde donor activity is unknown\",\n        \"Structural basis for the altered donor specificity was not determined\",\n        \"In vivo metabolic consequences of altered specificity were not tested\"\n      ]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"Key unresolved questions include the structural basis for DERA recruitment to stress granules, whether enzymatic activity is required for the stress-protective phenotype, and the physiological significance of DERA's catalytic promiscuity in human cells.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\n        \"No separation-of-function mutant distinguishing catalytic and stress granule roles\",\n        \"Human DERA crystal structure with C-terminal tail resolved is lacking\",\n        \"In vivo metabolic flux through the DERA pathway in human tissues has not been measured\"\n      ]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0016829\", \"supporting_discovery_ids\": [0, 1, 2, 3, 5, 7]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005829\", \"supporting_discovery_ids\": [2]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-1430728\", \"supporting_discovery_ids\": [1, 2]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\"YBX1\"],\n    \"other_free_text\": []\n  }\n}\n```"}